Prediabetes Explained — Your Numbers, the Range, and What They Actually Mean
Prediabetes is a lab pattern, not a feeling — any one of A1C 5.7–6.4%, fasting 100–125 mg/dL, or 2-hour OGTT 140–199 mg/dL puts you in the range, and it is often reversible when caught early.

Short Answer
Prediabetes means your blood sugar is running higher than your body wants, but not high enough to meet the lab definition of diabetes. Clinically, the range is defined by three common tests, and any one of them can place you in the prediabetes zone: an HbA1c of 5.7–6.4%, a fasting glucose of 100–125 mg/dL, or a 2-hour glucose of 140–199 mg/dL on an oral glucose tolerance test, using American Diabetes Association thresholds. (diabetes.org)
The frustrating part is that prediabetes usually does not feel dramatic. You may sleep, work, exercise, and eat more or less the way you always have and still have no clear symptoms. That is why it is often found only when a clinician orders blood work. Inside the body, though, the story is already moving: your cells are responding less efficiently to insulin, your pancreas may be working harder to keep glucose controlled, and your average glucose starts drifting upward before it becomes obvious day to day. (diabetes.org)
The good news is that this is not an automatic one-way road to type 2 diabetes. For some people, early treatment and sustained changes can move glucose back toward the normal range. Food patterns, regular movement, sleep, stress load, and weight all matter because they influence how much glucose enters your bloodstream, how well your muscles use it, and how hard insulin has to work. Lifestyle programs modeled on diabetes-prevention research have been shown to substantially lower the risk of progressing to type 2 diabetes. (diabetes.org)
Prediabetes matters on its own, too — not only as a "pre" stage. Long-term cohort research has linked prediabetes with higher risks of cardiovascular, kidney, heart-failure, mortality, and other complications, even when researchers account for later progression to diabetes. That does not mean a single lab result predicts your future. It means the result is a useful early warning: your metabolism is asking for attention before the damage becomes harder to reverse. (PMC11732724)
A wearable cannot tell you your HbA1c or diagnose prediabetes. But the patterns it tracks — sleep duration, sleep regularity, resting heart rate, recovery, stress load, and heart-rate variability — can still help you see the conditions your metabolism is living in. Poor sleep can make blood sugar harder to manage and can shift hormones such as insulin and cortisol in the wrong direction; stress and illness can also push glucose higher. So your wearable is not a glucose test. It is context you can bring to the conversation. (cdc.gov)
Prediabetes range at a glance
The prediabetes range means your blood sugar is running higher than your body wants, but not high enough to meet the lab criteria for diabetes. The American Diabetes Association lists these cut points for A1C, fasting plasma glucose, and the 2-hour oral glucose tolerance test. (diabetes.org)
| Test | Normal | Prediabetes range | Diabetes |
|---|---|---|---|
| HbA1c (A1C) | Below 5.7% | 5.7–6.4% | 6.5% or above |
| Fasting plasma glucose | Below 100 mg/dL | 100–125 mg/dL | 126 mg/dL or above |
| Oral glucose tolerance test (2-hour) | Below 140 mg/dL | 140–199 mg/dL | 200 mg/dL or above |
You don't have to land in the prediabetes range on all three tests for the result to matter. If your A1C, fasting glucose, or 2-hour OGTT is in that middle zone, it's enough to flag that your glucose regulation is under strain and should be discussed with a clinician. A1C reflects your average blood glucose over about the past two to three months; fasting plasma glucose is a snapshot after at least 8 hours without food or drink other than water; OGTT shows how your body handles a sugar load over two hours. ADA notes that diagnostic testing is usually repeated on a second day to diagnose diabetes, unless glucose is very high or classic high-blood-sugar symptoms are present, so one abnormal or borderline result often leads to confirmation — not panic. (diabetes.org)
What prediabetes actually is
Prediabetes means your blood glucose is higher than normal, but not high enough to be diagnosed as type 2 diabetes. Most of the time, the problem starts earlier than the lab result: your body is still making insulin, but your muscle, fat, and liver cells are not responding to it as cleanly as they should. So glucose has a harder time moving out of the blood and into cells, and blood sugar starts to run high in the background. Many people feel nothing at this stage, which is why prediabetes is diagnosed by blood tests, not by symptoms. (niddk.nih.gov)
The prediabetes range is an HbA1c of 5.7–6.4%, a fasting plasma glucose of 100–125 mg/dL, or a 2-hour oral glucose tolerance test value of 140–199 mg/dL. These numbers are not a character judgment or a life sentence. They are a signal: your metabolism is under strain, and the strain is measurable. (cdc.gov)
One thing worth being honest about: prediabetes is not just a countdown to diabetes. Large cohort data suggest it can carry elevated risk on its own, even when a person does not go on to develop diabetes. In the ARIC cohort analysis (n = 10,310), the authors report that "Prediabetes was modestly associated with risk of any complication (HR 1.21 [95% CI 1.15, 1.27]) vs normoglycaemia," and that "This association remained significant after accounting for progression to diabetes (HR 1.18 [95% CI 1.12, 1.24]) with 85% (95% CI 75, 94%) of the excess risk of any complication in prediabetes remaining" — in short, "Prediabetes contributes to the risk of clinical outcomes even without progression to diabetes." This is why prediabetes is treated as a signal to act, not ignored. (PMC11732724)
The numbers, and how common this is
Prediabetes is common because it usually stays quiet. Your glucose can run higher than normal for years without thirst, blurred vision, weight change, or any obvious "diabetes" signal. That is why population studies keep finding a large hidden group: people whose blood sugar is already in the prediabetes range, or even the diabetes range, without knowing it.
In one national survey in Cambodia (analyzed HbA1c sample n = 4,427), researchers looked for "Pre-diabetes (Haemoglobin A1c (HbA1c) 5.7%-6.4%) and UDD (HbA1c≥6.5%), without prior knowledge of having type 2 diabetes (T2D)" and found that "The weighted prevalences of pre-diabetes and UDD were 26.4% (95% CI 24.0% to 29.0%) and 9.3% (95% CI 7.9% to 11.0%)." Prevalence varies by country, testing method, age, and population. In the United States, the CDC's National Diabetes Statistics Report estimates that 115.2 million U.S. adults aged 18 years or older have prediabetes; CDC patient-facing guidance summarizes this as "more than 2 in 5 adults," with about 8 in 10 not knowing they have it. (PMC12815103 · cdc.gov)
That "not knowing" part matters. Prediabetes is not a diagnosis you can reliably feel. It is a lab pattern: glucose regulation is already strained, but the body may still be compensating enough that daily life feels normal.
Progression is common, but it is not automatic. In the ARIC cohort, many people with prediabetes did not move quickly into diabetes, and that time window is the point: it is the runway where sleep, movement, food timing, weight change, stress physiology, and medication decisions can still shift the curve. The authors note that "Of the 60% of adults with prediabetes at baseline, ~30% progressed to diabetes (median time to diabetes, 7 years)." A median of 7 years is not a guarantee and not a deadline; it means progression often unfolds over years, which is exactly why early action can matter. (PMC11732724)
Can prediabetes be reversed? "Reverse prediabetes in 3 months" — what's realistic
This is the hope people search for at 11 p.m.: can I reverse prediabetes in 3 months? The straight answer is: you can often push your glucose numbers back toward the normal range and meaningfully cut your risk of type 2 diabetes — but "reverse" is not a promise, and 3 months is not a magic deadline.
Prediabetes is not just one lab value sitting in isolation. It usually means your muscles, liver, and fat tissue are not responding to insulin as cleanly as they should. Your pancreas has to work harder to keep blood sugar in range. When you change the inputs — food timing and quality, movement, sleep, stress load, weight, alcohol, and medication decisions with your clinician — you can lower that pressure on the system. Sometimes the lab number moves quickly. Sometimes it takes longer. The evidence is strongest for structured, sustained lifestyle change, not a short crash reset.
In a culturally tailored lifestyle-program RCT in adults with prediabetes, the authors report that "The intervention group had a significantly lower 12-month cumulative T2D incidence (9.8% [95% CI, 7.1%-13.5%]) vs the control group (17.1% [95% CI, 13.4%-21.6%]), with an absolute risk reduction of 7.3 percentage points (95% CI, 5.2-10.6 percentage points), a relative risk reduction of 42.5% (95% CI, 15.0%-70.0%), and a number needed to treat of 14 (95% CI, 9-39)" — with "the hazard ratio was 0.75 (95% CI, 0.60-0.95; P = .02), corresponding to a 25.0% reduction in diabetes risk." (PMC12538358)
That trial points in the same direction as the landmark U.S. Diabetes Prevention Program. In the DPP, 3,234 high-risk adults were assigned to placebo, metformin, or an intensive lifestyle program with goals of at least 7% weight loss and at least 150 minutes of physical activity per week; after an average 2.8 years, the lifestyle intervention reduced the incidence of type 2 diabetes by 58 percent compared with placebo (metformin by 31 percent). (PMID 11832527)
So if you want the realistic version of "reverse prediabetes in 3 months," it is this: a 3-month recheck can show progress, but the risk reduction data come from repeatable habits carried over months and years. The CDC's National Diabetes Prevention Program is built as a structured, yearlong lifestyle change program, and CDC summarizes its core evidence as a 58% lower risk of type 2 diabetes through these changes. (cdc.gov)
Two honest caveats belong here.
First, benefits track with consistency and modest, maintainable weight loss — not a crash diet that leaves you exhausted, hungry, and rebounding. A synthesis of lifestyle interventions in type 2 diabetes with obesity describes "clinically significant weight loss (5-15% of body weight) associated with improved metabolic control, diabetes remission in patients achieving ≥15kg weight reduction, and reduced reliance on glucose-lowering medications" — though that evidence is drawn from a type 2 diabetes-with-obesity population, not prediabetes specifically. For prediabetes, the practical target is often smaller than people fear. CDC describes "a small amount of weight loss" as about 5% to 7% of body weight and pairs it with regular physical activity — at least 150 minutes a week of brisk walking or similar movement. That is not glamorous. It is also exactly why it can work: your cells see the signal again and again. (PMC12495976 · cdc.gov)
Second, lighter-touch digital nudges do not always move the lab number. An app, text message, or checklist can support behavior, but it may not be enough by itself if your sleep is short, your stress physiology is constantly switched on, your meals keep spiking glucose, or your movement is too rare to change insulin sensitivity. In one SMS-based digital-intervention trial, "intervention A led to a small, nonsignificant reduction in HbA1c levels compared to the control group (β=-0.05, 95% CI -0.21 to 0.10; P=.50), whereas intervention B showed a similar nonsignificant reduction (β=-0.04, 95% CI -0.12 to 0.10; P=.56)." (PMID 41067715)
That does not mean digital tools are useless. It means the question is not "did I try something?" The question is: did my body get enough of the right signal, often enough, to change glucose handling? For most people, that signal is boring in the best way: meals that reduce glucose overload, muscle work most days, sleep that lets insulin sensitivity recover, and stress regulation that gives your nervous system fewer reasons to keep glucose available for an emergency that never comes.
Does insurance cover a CGM for prediabetes?
A continuous glucose monitor (CGM) can show your glucose rising, falling, and responding to meals, exercise, sleep, stress, and medication in real time. That feedback can feel especially useful when you've been told you have prediabetes and want to catch patterns before they turn into diabetes.
In the U.S., though, insurance coverage for a CGM for prediabetes is usually not standard. The cleanest way to think about it is this: CGM coverage is built around diabetes management, especially when insulin use or documented problematic hypoglycemia makes continuous monitoring medically necessary. The American Diabetes Association's Medicare CGM coverage summary describes expanded access for people with diabetes who either use insulin or meet criteria for problematic hypoglycemia; it does not frame prediabetes alone as a typical coverage category. (diabetes.org)
That does not mean you can't get a CGM. Some clinicians may prescribe one off-label or for short-term pattern-finding, some plans may make exceptions, and some people pay out of pocket. FDA clearance has also widened access to over-the-counter CGM technology for adults who do not use insulin, including people without diabetes who want to understand how food and exercise affect glucose. But FDA availability is not the same as insurance coverage. (fda.gov)
So if your question is, "Does insurance cover a CGM for prediabetes?" the practical answer is: maybe, but don't assume it will. Ask your insurer what diagnosis codes and documentation they require, ask your clinician whether there is a medical reason to request coverage, and check whether your plan treats CGM as pharmacy or durable medical equipment. Prediabetes screening tests, such as glucose testing and A1C, are a different coverage category from wearing a CGM device continuously. (niddk.nih.gov)
Where Welltory fits: Welltory does not measure blood glucose and is not a CGM. What it does track — overnight HRV, resting heart rate, sleep, and stress load — can help you see the strain patterns that often travel alongside glucose dysregulation: poor sleep, high sympathetic load, slower recovery, and a body that stays "on" when it should be restoring. That context does not replace glucose data, but it can help you understand what your body is doing between lab tests and daily choices.
The Welltory angle: sleep, stress, HRV — the metabolic picture a wearable can see
Welltory can't tell you your glucose. Prediabetes is diagnosed with blood tests — such as A1C, fasting plasma glucose, or an oral glucose tolerance test — not with heart-rate data. But glucose control doesn't happen in isolation. Your blood sugar sits inside a bigger body system: sleep timing, circadian rhythm, stress physiology, recovery, inflammation, appetite signals, and autonomic balance all push on the same metabolic machinery. Heart-rate and HRV data live in that neighborhood: they reflect how your autonomic nervous system is shifting between strain and recovery, even though they do not measure glucose directly. (cdc.gov)
Reduced heart-rate variability tracks with autonomic dysfunction in people with prediabetes and diabetes. That matters because autonomic dysfunction is not just "feeling stressed." It is the body's control system for heart rate, blood-vessel tone, digestion, and recovery becoming less flexible — the kind of change that can show up early, before someone feels obviously sick. In one study of people with prediabetes and type 2 diabetes, the authors "tested the ability of simple heart rate (HR)-based measures-namely, resting HR variability (HRV), post-exercise HRV, and HR recovery (HRR)-to identify cardiovascular autonomic neuropathy (CAN) in individuals with prediabetes and type 2 diabetes (T2D)." (PMC12508516)
Sleep and circadian disruption feed straight into glucose handling. Short or irregular sleep can make the body less insulin-sensitive; poor sleep quality is tied to more glycemic variability in diabetes studies; circadian misalignment can disturb insulin sensitivity and insulin secretion. In plain English: when your sleep is short, fragmented, or mistimed, your cells may become worse at taking up glucose, and your liver, hormones, and nervous system may keep sending "not recovered yet" signals. One review notes that "Sleep disorders affect hormone production and secretion, which lead to endocrine changes, including impaired glucose tolerance, decreased insulin sensitivity, hepatic steatosis, and increased inflammatory responses," and a separate review of diabetes studies found that "Poor sleep quality and short sleep duration correlated with higher glycemic variability." (PMC12315459 · PMC12554434)
The practical takeaway: tracking sleep regularity, resting HR trends, and HRV won't diagnose prediabetes, and it should not replace lab testing or medical care. But it can surface the lifestyle levers that often sit upstream of glucose control — sleep debt, inconsistent bedtimes, low recovery, high stress load, and a resting heart rate that keeps creeping up. Those are not "soft" signals. They are body signals. And they can help you notice when your metabolic system may be under pressure before your next A1C tells the story.
When to get tested
Because prediabetes is usually quiet in the body, you often won't feel a clear "glucose problem" before a lab catches it. Testing is how it's found: an A1C, fasting plasma glucose, or oral glucose tolerance test done through a clinician or lab. Ask about screening if you're 35 or older, or sooner if you have overweight or obesity plus another risk factor — a parent or sibling with diabetes, a history of gestational diabetes, PCOS, high blood pressure, low physical activity, cardiovascular disease, or other signs of insulin resistance. If you've already had prediabetes, yearly testing is typically recommended; if you had gestational diabetes, testing at least every 1–3 years is recommended. (PMC12690183)
Your wearable can help you notice that something is changing, but it can't diagnose prediabetes. A creeping resting heart rate, worse sleep, lower recovery, or a pattern of feeling more drained than usual is a reasonable reason to bring the conversation forward: "Should we check my glucose and A1C?" The answer still comes from blood work, not from an app score — but your trends can be the nudge that gets you tested before symptoms ever show up. (medlineplus.gov)
How we made it
Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.


Discounts for blog readers: up to 36% off
See what affects your energy, stress, sleep, and daily state with Welltory
This article is for educational purposes only and does not replace medical diagnosis or treatment. Prediabetes is diagnosed with lab testing in a healthcare setting. A consumer wearable, smartwatch, or smart ring cannot diagnose prediabetes or measure blood glucose on its own. A CGM is a medical glucose device, not the same thing as a wellness wearable. Talk to a qualified provider about your results.
Was this helpful?
Ask AI for a summary of page
Written by Jane Smorodnikova
The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.
Written by Kseniia Iaroslavtseva
Reviewed by Anna Elitzur
With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.
References
- American Diabetes Association Professional Practice Committee — Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026; criteria defining prediabetes in nonpregnant individuals: A1C 5.7–6.4%, FPG 100–125 mg/dL, or 2-hour PG during 75-g OGTT 140–199 mg/dL. https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/
- CDC — National Diabetes Statistics Report; U.S. prediabetes prevalence: 115.2 million adults aged ≥18 years with prediabetes. https://www.cdc.gov/diabetes/php/data-research/
- Diabetes Prevention Program Research Group — Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin; canonical DPP result: lifestyle intervention reduced diabetes incidence by 58% versus placebo, and metformin by 31%, over an average 2.8 years. https://pubmed.ncbi.nlm.nih.gov/11832527/
- Selvin E, et al. — Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes; ARIC cohort, n = 10,310, with elevated complication risk persisting after accounting for progression to diabetes. https://pmc.ncbi.nlm.nih.gov/articles/PMC11732724/
- Prevalence and factors associated with pre-diabetes and undiagnosed diabetes in Cambodia: cross-sectional study based on the World Health Survey Plus 2023; national survey, final analysed HbA1c sample n = 4,427, weighted prediabetes prevalence 26.4% and undiagnosed diabetes 9.3%. https://pmc.ncbi.nlm.nih.gov/articles/PMC12815103/
- Bhowmik B, et al. — Faith-Based Lifestyle Intervention for Diabetes Prevention Among Adults in Bangladesh: A Cluster Randomized Clinical Trial; adults with prediabetes randomized n = 799, with 641 completing 12-month follow-up; intervention group T2D incidence 9.8% vs control 17.1%. https://pmc.ncbi.nlm.nih.gov/articles/PMC12538358/
- Mira-Martínez S, et al. — A Multifaceted Digital Intervention for the Prevention of Type 2 Diabetes Mellitus in Primary Care (PREDIABETEXT): Cluster Randomized Trial; SMS-based digital intervention did not significantly improve HbA1c. https://pubmed.ncbi.nlm.nih.gov/41067715/
- Evidence-Based Synthesis for Practice: Lifestyle Interventions in Type 2 Diabetes with Obesity; clinically significant weight loss 5–15% associated with improved metabolic control, and ≥15 kg weight reduction linked with diabetes remission in the reviewed evidence (type 2 diabetes-with-obesity population). https://pmc.ncbi.nlm.nih.gov/articles/PMC12495976/
- Diagnostic value of heart rate-based methods for assessing cardiac autonomic neuropathy in prediabetes and diabetes; resting HRV, post-exercise HRV, and heart-rate recovery assessed for identifying cardiovascular autonomic neuropathy in people with prediabetes and T2D. https://pmc.ncbi.nlm.nih.gov/articles/PMC12508516/
- Jiao Y, et al. — Sleep disorders impact hormonal regulation: unravelling the relationship among sleep disorders, hormones and metabolic diseases; sleep disorders linked with impaired glucose tolerance, decreased insulin sensitivity, hepatic steatosis, and inflammatory responses. https://pmc.ncbi.nlm.nih.gov/articles/PMC12315459/
- Sleep patterns in adults and children with less common forms of diabetes; poor sleep quality and short sleep duration correlated with higher glycemic variability in reviewed diabetes studies. https://pmc.ncbi.nlm.nih.gov/articles/PMC12554434/


-2.jpg)
